Our proprietary platforms serve as the foundation for advanced implants that repair and regenerate tissue, bone, and muscle. Based on safe and biocompatible biomaterials such as collagen, bio-glass, and synthetic polymers, our solutions have been used to develop some of today’s most notable medical innovations.
Optimizing tissue engineering requires deep experience in chemistry, processing, and design. With 25+ years of innovation in regenerative science, we’re adept at tuning the physical characteristics of biomaterials to achieve desired mechanical and surface properties. By incorporating active agents into our devices, we can enable essential capabilities such as hemostatic or inflammatory modulators that foster wound healing.
Through a distinctive set of materials and processes, Regenity Biosciences develops transformative solutions across several clinical segments, including dental, neurosurgery, sports medicine, spine, orthopedics, and more.
Isolation and purification of xenograft derived type I collagen fibers involves sequential…
This technology platform encompasses purification and processing of intact animal tissue; purified,…
Regenity Biosciences has developed proprietary methods for coating devices with type I collagen…
Derived from animal bone as well as synthetic carbonate apatite, our natural carbonate apatite is…
Incorporation of minerals into a 3-D collagen matrix is used to develop composites with a…
Our biocomposite technology platform involves the integration of collagen and minerals with our…
Our synthetic aliphatic poly (DL-lactide-ε-caprolactone) copolyesters are exclusive, biodegradable…
Biodegradable polyurethanes form the basis of our proprietary multi-block copolymer technology. The…
This adhesive platform is based on a synthetic multi-arm polyethylene glycol (PEG) functionalized…
We support and develop tissue regenerating supportive additives, components, and ingredients, which…
We help our medical technology clients solve unmet needs, such as improving leak resistance or stimulating tissue growth. This involves identifying the optimal material or technology platform to achieve their goals and then applying our proprietary processing to the platform material to reach the end specifications. Through proprietary techniques, we’re able to adapt each process to make a dramatic difference in material handling and performance.
As a leading developer of devices for bone grafts, dental wounds, sports medicine injuries, dural and nerve repair, as well general and ENT surgery, Regenity is advancing the next frontiers of regenerative implant science.
Our distinct approach to product development makes a material difference. Through proprietary processing techniques and platforms, we’ve demonstrated predictable and consistent material performance properties and handling across our product portfolio.
Since its inception, Regenity has helped medtech clients secure regulatory approval for more than 71 product lines.